RBC Capital analyst Brian Abrahams maintained a Hold rating on SAGE Therapeutics (SAGE – Research Report) yesterday and set a price target of ...

RBC Capital analyst Ben Hendrix maintained a Buy rating on Humana (HUM – Research Report) yesterday and set a price target of $283.00. The ...

Fintel reports that on February 10, 2025, RBC Capital downgraded their outlook for Pliant Therapeutics (NasdaqGS:PLRX) from ...

EOG Resources Inc. (NYSE:EOG) received an upgraded stock rating from RBC Capital Markets, moving from Sector Perform to Outperform. Alongside the rating change, EOG Resources also saw its price target ...

RBC Capital lowered the firm’s price target on PepsiCo (PEP) to $164 from $172 and keeps a Sector Perform rating on the ...

RBC Capital raised the firm’s price target on Affirm (AFRM) to $81 from $67 and keeps a Sector Perform rating on the shares. The company delivered a strong quarter with beats across the board and an ...

In this article, we are going to take a look at where International Business Machines Corporation (NYSE:IBM) stands against ...

On Wednesday, RBC Capital issued a downgrade for FMC Corp . (NYSE:FMC) from Outperform to Sector Perform, significantly reducing the price target to $47.00 from the previous $78.00. The decision ...

Investing.com -- RBC Capital Markets in a note dated Friday raised its price target for LVMH Moët Hennessy Louis Vuitton to €780 from €700 following the Luxury goods company’s fourth ...

RBC Capital Markets head of global energy research Greg Pardy has made two changes to his Global Energy Best Ideas list, removing Archrock Inc. and Pacific Gas and Electric Co., “In January ...

Looking at stellar Q4 results, strong US commercial growth, and increasing AI adoption, here’s what we think of Palantir stock. We sell different types of products and services to both ...

On January 30, RBC Capital analyst Matthew Swanson raised the firm’s price target on the stock to $276 from $250 and kept an “Outperform” rating on the shares. According to the firm ...